Daniel D. Von Hoff
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research 170
- Cancer Treatment and Pharmacology 124
- Colorectal Cancer Treatments and Studies 62
- Cancer-related Molecular Pathways 41
- Lung Cancer Research Studies 39
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 112
- Molecular Biology top 0.05%
- Cancer therapeutics and mechanisms 100
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 45
- Genetics top 0.2%
- Co-authors
- Haiyong HanHoward A. BurrisMace L. RothenbergMalcolm J. MooreJohn Sahl AndersenM. Christine CrippsPeter G. TarassoffAnna Maria Storniolo
- Journals
- Journal of Clinical Oncology (126 papers)Investigational New Drugs (45 papers)Cancer Research (44 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Daniel D. Von Hoff
805 papers receiving 43.5k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Oncology 23.6k
- Cancer Research 8.3k
- Molecular Biology 19.7k
- Pulmonary and Respiratory Medicine 6.7k
- Genetics 2.1k
Countries citing papers authored by Daniel D. Von Hoff
This map shows the geographic impact of Daniel D. Von Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Von Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Von Hoff more than expected).
Fields of papers citing papers by Daniel D. Von Hoff
This network shows the impact of papers produced by Daniel D. Von Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Von Hoff. The network helps show where Daniel D. Von Hoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel D. Von Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 69 | |
| 2 | 2018 | 27 | |
| 3 | 2017 | 120 | |
| 4 | 2016 | 215 | |
| 5 | 2015 | 102 | |
| 6 | Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancerbreakdown → | 2015 | 469 |
| 7 | 2012 | 86 | |
| 8 | 2011 | 50 | |
| 9 | 2011 | 90 | |
| 10 | 2011 | 26 | |
| 11 | 2011 | 420 | |
| 12 | 2011 | 97 | |
| 13 | 2011 | 21 | |
| 14 | 2011 | 66 | |
| 15 | 2009 | 11 | |
| 16 | 2009 | 42 | |
| 17 | 2009 | 462 | |
| 18 | 2009 | 86 | |
| 19 | 2008 | 20 | |
| 20 | 2006 | 58 |
About Daniel D. Von Hoff
Daniel D. Von Hoff is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 821 papers that have together received 44.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (170 papers), Cancer Treatment and Pharmacology (124 papers), Cancer Genomics and Diagnostics (112 papers), Cancer therapeutics and mechanisms (100 papers), Colorectal Cancer Treatments and Studies (62 papers), Lung Cancer Treatments and Mutations (45 papers), Cancer-related Molecular Pathways (41 papers) and Lung Cancer Research Studies (39 papers). The work is most often cited by research in Oncology (23.6k citations), Cancer Research (8.3k citations) and Molecular Biology (19.7k citations). Daniel D. Von Hoff has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Haiyong Han, Howard A. Burris, Mace L. Rothenberg, Malcolm J. Moore, John Sahl Andersen, M. Christine Cripps, Peter G. Tarassoff, Anna Maria Storniolo, Russell K. Portenoy and F. Andrew Dorr. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Cancer Research, Molecular Cancer Therapeutics and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.